Additive manufacturing - an antidote to bottlenecks in tissue engineering and regenerative medicine
Yifan Li, Fabian Tribukait-Riemenschneider, Yawei Gu, V Prasad Shastri · 2026
Read Additive manufacturing - an antidote to bottlenecks in tissue engineering and regenerative medicine by Yifan Li, Fabian Tribukait-Riemenschneider, Yawei Gu, V Prasad Shastri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617271.txt.
Description
Yifan Li and three colleagues review additive manufacturing, better known as 3D printing, as a remedy for the production bottlenecks holding back tissue engineering and regenerative medicine. Building living tissue requires exact control of structure, cell placement, and reproducibility, which traditional fabrication struggles to deliver. Printing promises to translate digital designs into three-dimensional constructs with defined shape and internal architecture.
Working through examples of bone-cartilage units, skin, and vascular grafts, the review tests where printing truly helps: structural fidelity, spatial patterning, digital reproducibility, and tailoring to the patient. The authors also weigh stubborn limits, including bioink trade-offs, resolution limits, and regulatory barriers. Their verdict is that being printable does not guarantee biological function. Clinical success will hinge on proving tissue maturation, integration with the host, and compliance within real hospital workflows, helped by data-driven design.
Catalog record
| CREATOR | Yifan Li, Fabian Tribukait-Riemenschneider, Yawei Gu, V Prasad Shastri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |